LOW INCIDENCE OF MALIGNANCY AMONG RENAL TRANSPLANT RECIPIENTS TREATED AT A SINGLE CENTER FOR 1–10 YEARS WITH A SIROLIMUS-CYCLOSPORINE REGIMEN

Authors :: L. Schoenberg
Richard J. Knight
W E. Etheridge
Yarkın Kamil Yakupoğlu
Stephen M. Katz
Kahan Bd
C. T. Van Buren
Source :: Transplantation. 78:34-35
Publication Year :: 2004
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2004.

Subjects :: Transplantation
medicine.medical_specialty
business.industry
Incidence (epidemiology)
Urology
Single Center
Malignancy
medicine.disease
Regimen
Renal transplant
Sirolimus
Medicine
business
medicine.drug

Tools